Feed-grade choline chloride 60% on a vegetable or silica carrier is normally metered into monogastric premixes at the point of addition downstream from mineral and trace element dispensing. The carrier is specified with a moisture content of 2.0–3.5% and a particle size distribution where not more than 5.0% remains on a 2.00 mm sieve and not more than 8.0% passes through a 0.20 mm sieve. This fraction is selected to reduce segregation in finished feed rather than to improve chemical stability alone. In vertical screw mixers of 2.0 m³ working capacity, a 6–8 min mixing cycle is required after the choline carrier is introduced. The target coefficient of variation for choline chloride is 5.0% or lower across 10 sampling points when assayed by the method specified in the feed additive registration dossier. Separation is observed when the premix is transferred pneumatically after mixing; a dense-phase conveying velocity below 8 m/s is used to preserve the distribution. Choline chloride on vegetable carrier is stored in closed silos at relative humidity below 60% and ambient temperature below 30 °C. Direct contact with ferrous sulfate, zinc oxide, and manganese oxide is avoided because the free moisture released from choline chloride accelerates oxidative destruction of vitamins A and D₃. The finished premix is intended for inclusion at 0.25–0.50% in complete feed, with the 60% product typically delivering 400–1,200 mg choline chloride per kilogram of finished feed depending on species and production stage. The manufacturing line complies with FDA 21 CFR 507 preventive controls for animal food and with feed additive authorization under EU Regulation (EC) No 1831/2003.

Why Does Direct Compression Choline Tableting Demand Dry Granulation?

Choline chloride in tablet form is not direct-compressed unless the raw material water activity is maintained below a defined threshold and the tableting suite is conditioned to ≤25% relative humidity at 20–25 °C. The chloride salt is hygroscopic; at relative humidity above 40%, free moisture increases from 2.5% to 8.0% within 4 h in open trays. Wet granulation is excluded because aqueous binder addition mobilizes choline chloride and creates a sticky mass that adheres to high-shear granulator bowls and fluid-bed dryer screens. The preferred route is dry granulation by roller compaction. A 60% choline chloride on corn cob or silica is blended with 12.0% microcrystalline cellulose PH102, 4.0% crospovidone, 1.5% colloidal silicon dioxide and 0.5% magnesium stearate. The blend is compacted on a roller compactor with 100 kN roll force and a 0.8 mm rotor screen. The granules are compressed on a 20-station tablet press to a final hardness of 8–12 kp and friability below 1.0% according to USP <1216>. Tablet mass is typically 1.0 g to provide 250 mg choline bitartrate per unit in a companion-animal liver support formulation. Disintegration testing follows USP <701>; the tablets disintegrate within 15 min in 0.1 N hydrochloric acid because crospovidone acts by capillary wicking rather than swelling. Water content is measured by USP <921> and is controlled to below 3.0% after 24 h at 25 °C and 75% RH in open dish conditions.

Hard Gelatin Capsule Fill Parameters for Choline Bitartrate–Silicified Microcrystalline Cellulose Blends

In capsule filling bays operating at relative humidity above 35%, free choline chloride transfers moisture to gelatin capsule shells within 24 h. For this reason, choline bitartrate is preferred over the chloride salt for hard gelatin capsule formulations. The blend is prepared by geometric dilution of choline bitartrate with silicified microcrystalline cellulose 90M and 1.0% magnesium stearate. The target fill weight for size 0 capsules is 450 mg ± 5.0%. Tapped density is maintained at 0.60–0.65 g/mL to keep the tamping pin fill station within 5% weight variation. Automatic capsule machines fitted with tamping pins are set to 80 strokes/min and pin compression depth of 2.0 mm. The filled capsules are transferred to HDPE bottles containing 1.0 g silica gel canisters. A desiccant canister is required when the label stores the product in climate zone IVb conditions where the average relative humidity exceeds 75% for at least 12 weeks/year. Water content of the finished capsule is determined by USP <921> and must not exceed 5.0% after 3 months at 25 °C and 60% RH. Disintegration testing is conducted according to USP <701>. Choline bitartrate is selected because it is physically less deliquescent than choline chloride and does not introduce a high chloride load to the capsule shell, which would otherwise plasticize gelatin in storage.

Thermal Stability in Aqueous Choline Chloride Injection Is Not Guaranteed by Monograph Identity Testing Alone

For parenteral choline formulations, the API is dissolved in Water for Injection under nitrogen sparging to minimize oxidative discoloration. The target concentration is typically 10.0–20.0% w/v choline chloride, adjusted to pH 6.0–6.5 with 0.1 N hydrochloric acid or 0.1 N sodium hydroxide as needed. The solution is filtered through a 0.22 µm PVDF membrane and aseptically filled into amber Type I glass vials. Terminal autoclaving at 121 °C for 15 min is not specified as a default because choline chloride in aqueous solution can undergo Hofmann elimination to trimethylamine and ethylene glycol derivatives under alkaline conditions; the rate accelerates at pH above 7.5. When terminal sterilization is required, the fill volume and headspace oxygen are controlled to below 2.0% v/v, and the batch size is limited by a post-sterilization assay for trimethylamine. Particulate matter is evaluated according to USP <788>. Sterility testing follows USP <71>, and bacterial endotoxin testing follows USP <85>. The product is labeled for single-dose administration in neonatal calves or foals when oral milk intake is inadequate. Published data for this specific configuration is limited, so formulation stability must be generated on a batch-specific basis rather than extrapolated from monograph identity tests.

When Soluble Choline Premix Is Added to Drinking Water Lines

Drinking water lines in broiler houses are composed of polyethylene or PVC tubing with inner diameters of 20–25 mm and are frequently sanitized with chlorine-based oxidizers. A water-soluble choline chloride formulation must dissolve rapidly without forming amine odours when diluted. The product is manufactured by absorbing 60% choline chloride onto precipitated silica that has an oil absorption of 30–40 g/100 g and blending with 2.0% sodium citrate as a pH buffer. The final powder is packaged in polyethylene-lined aluminium pouches at 20 kg net weight. Typical use dilution is 0.5–1.0 g of 60% choline chloride per litre in drinking water for broiler starter periods. A 1:128 medicator is used to inject stock solution at a rate that maintains the target concentration. The pH of the final drinking water is kept between 4.0 and 6.0 because acidic pH stabilizes the quaternary ammonium structure. Mixing with alkaline sanitizers is avoided because free trimethylamine formation increases above pH 8.0. The powder is not hygroscopic at packaging moisture below 3.0%; however, opened bags must be consumed within 24 h when ambient relative humidity exceeds 70%. Dissolution is tested by adding 10 g to 1.0 L of 20 °C water with stirring at 60 rpm for 5 min. The acceptance criterion is a clear or slightly turbid solution with no retained particles on a 0.25 mm sieve.

Maltodextrin and colloidal silicon dioxide are blended with choline chloride 60% before dry compaction to form free-flowing granules intended for oral drenching. Roller compaction is selected over wet extrusion because water addition at more than 4.0% produces a plastic mass that fouls the barrel and generates trimethylamine during drying. The compacted ribbons are milled and classified to a 0.8–1.6 mm particle size. Bulk density is set at 0.62 g/cm³ to allow consistent metering in drenching guns. The granules are filled into single-dose sachets or HDPE jars with induction-sealed liners. In pre-ruminant calves, the granules are dispersed in milk replacer or water immediately before administration. The dispersion is prepared at 20–30 g granules per 2.0 L of water, with gentle agitation for 60 s at 25 °C. Foaming is controlled by the particle size distribution rather than by antifoam agents. A laser diffraction particle size test is performed using the Fraunhofer model; D[4,3] is controlled between 0.9 mm and 1.4 mm. Moisture content is measured by USP <921> and maintained below 3.5% in the sealed package. The final product is homogeneous when sampled by a spinning riffler; the coefficient of variation for choline chloride across 12 samples is below 5.0%.

Concentrated aqueous oral drench solutions based on choline chloride are manufactured at 40.0% w/v active material and filled into amber high-density polyethylene bottles with polypropylene child-resistant closures. The solution is not a simple dilution of feed-grade liquid choline chloride 70%; it requires filtration and deaeration to prevent oxygen bubbles from accelerating trimethylamine formation. The pH is adjusted to 5.5–6.5, and the fill line is blanketed with nitrogen. At 40.0% w/v, the solution has a density of 1.15–1.20 g/mL and a viscosity below 80 mPa·s at 20 °C. Oral drench guns are calibrated to deliver 5–10 mL per calf per day, equivalent to 2.0–4.0 g choline chloride. The bottle is stored at controlled room temperature below 25 °C; phase separation is not observed after 12 months if the closure maintains moisture vapour transmission below 0.5 g/m²/day. The main incompatibility is with alkaline oral rehydration solutions that raise the pH above 7.5. The product is tested for microbial limits using Ph. Eur. 2.6.12 and for extractable organic impurities by headspace gas chromatography; the trimethylamine specification is not more than 0.1%.